Not yet recruitingPhase 2
DOXYCYCLINE PENETRATION INTO BONE AND JOINT.
Key facts
- Who runs it
- Centre Hospitalier Universitaire De Caen Normandie
- Where
- France1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Not yet recruiting
- Phase
- Phase 2
- People taking part
- 30 people, planned
- Started
- 1 Jun 2026
- Expected to end
- 1 Jun 2027
- Type of study
- Interventional
- Record updated
- 20 July 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 18 criteriaShow less
Who can take part
- Age between 18 and 80 years old
- Scheduled for elective surgery for hip replacement due to coxarthrosis
- Signed informed consent
- Patients eligible for French social insurance; Participants able to fully understand the study and who accept its requirements and constraints
Who cannot take part
- Patient with a contraindication to surgical procedure
- Patient who has received antibiotics within one month prior to the procedure
- Patients with contraindications to doxycycline ( hypersensitivity to the active substance or to any of the excipients (particularly as generic formulations are authorized in the study and excipients may therefore differ), hypersensitivity to tetracycline-class antibiotics, co-administration of retinoids, or vitamin A supplementation exceeding 10,000 IU/day, due to the risk of intracranial hypertension and intestinal obstruction)
- history of osteoarticular infection related to hip prosthesis surgery
- Patient with an infection at the time of surgical management
- malabsorption syndrome or conditions likely to impair antibiotic absorption (sleevs, colectomy, gastrointestinal antacids (magnesium, aluminum, or calcium salts, oxides, or hydroxides) and oral iron salts……)
- Malnutrition patient (BMI < 21 kg/m2) or with serum albumin < 30g/L
- Kidney failure with GFR < 60 mL/min/1,73m2
- Women of childbearing age without effective contraception : childbearing age means non menopausal women. Effective contraception includes taking a contraceptive pill or using an Intra Uterine Device
- Patient who did not take Doxycycline as planned in the protocol
- Patient being a relative of the investigator or any member of the team directly involved in the study, including assistant physicians, pharmacists, nurses, and coordinators
- Patients unable to take oral doxycycline
- Pregnant or breastfeeding women
- Patients under guardianship, curatorship, legal protection or conservatorship
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The objective of this study is to provide robust data on bone penetration of the doxycycline in non-infected patient. The primary objective is to determine the penetration of doxycycline in cancellous bone.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record
Print a page for my doctorData and sources
- Registry record
- Listed on the EU's official list of trials (CTIS).
- Record updated
- 20 July 2026